Phase I study of gemcitabine, cisplatin, and S‐1 combination therapy for patients with untreated advanced biliary tract cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1868-6982|22|9|669-674

ISSN： 1868-6974

Source： JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol.22, Iss.9, 2015-09, pp. : 669-674

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabine and S-1 Combination Chemotherapy in Patients with Advanced Biliary Tract Cancer:A Retrospective Study

By  

Case Reports in Oncology, Vol. 3, Iss. 3, 2010-12 ,pp. : 498-504

Karger

Access to resources Recommend Favorite

Renal Toxicity Associated with Weekly Cisplatin and Gemcitabine Combination Therapy for Treatment of Advanced Biliary Tract Cancer

By  

Oncology, Vol. 87, Iss. 1, 2014-06 ,pp. : 30-39

Karger

Access to resources Recommend Favorite

Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 8, 2018-04 ,pp. : 1671-1675

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Phase I Study of Combination Chemotherapy with Gemcitabine and Oral S-1 for Advanced Pancreatic Cancer

By  

Oncology, Vol. 69, Iss. 5, 2005-12 ,pp. : 421-427

Karger

Access to resources Recommend Favorite

Feasibility and efficacy of gemcitabine plus cisplatin combination therapy after curative resection for biliary tract cancer

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 11, 2015-11 ,pp. : 789-794

John Wiley & Sons Inc

Access to resources Recommend Favorite